title: Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers.
abstract: The two-compartment tissue accumulation pharmacokinetics of tobramycin and netilmicin were compared in 11 normal volunteers by using a crossover design. After each 1.0-mg/kg (body weight) dose, serum was collected for 96 h, and complete 24-h urine collections were obtained for a total of 30 days. Two months of washout were required before crossover. Concentrations in serum and urine were measured by radioimmunoassay, and concentrations in serum and urinary excretion rates were simultaneously fitted to a two-compartment pharmacokinetic model. Netilmicin exhibited significantly lower total body clearance (48 versus 90 ml/min) and longer terminal elimination half-life (161 versus 96 h) than tobramycin. As a result of these pharmacokinetic differences, the predicted tissue accumulation of netilmicin at steady state was significantly higher than that of tobramycin (P less than 0.05). Relative rates of aminoglycoside nephrotoxicity probably depend on both the differential tissue uptake (accumulation) and the concentration of the aminoglycoside which produces intracellular toxicity. Because the steady-state tissue accumulation of netilmicin is nearly 2.5 times greater than that of tobramycin, its potency in the production of intracellular toxicity needs to be that much less for the two agents to produce the same incidence of clinical nephrotoxicity.
mesh_terms: D000328:Adult; D001825:Body Fluid Compartments; D006801:Humans; D007700:Kinetics; D008657:Metabolic Clearance Rate; D009428:Netilmicin / Q000008:administration & dosage / Q000378:metabolism*; D014031:Tobramycin / Q000008:administration & dosage / Q000378:metabolism*
chemical_list: D009428:Netilmicin; D014031:Tobramycin